PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23295110-12	2013	TNF-induced nuclear translocation of NF-kappaB was abolished by treatment with CZP.	Certolizumab Pegol	79-82	nuclear factor kappa B subunit 1	Homo sapiens	37-46	
23295110-14	2013	CONCLUSIONS: We have found at cellular level, that a clinically available TNF inhibitor, CZP i) reduces adhesion molecule expression; ii) prevents TNF-induced activation of the NF-kappaB pathway and iii) prevents the production of microparticles by activated endothelial cells.	Certolizumab Pegol	89-92	nuclear factor kappa B subunit 1	Homo sapiens	177-186